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Abstract (185 words) 
Female athletes are severely understudied in the field of concussion research, despite higher 
prevalence for injuries and tendency to have longer recovery time. Hormonal fluctuations due to 
normal menstrual cycle (MC) or hormonal contraceptive (HC) use have been shown to impact 
both post-injury symptoms and neuroimaging measures, but have not been accounted for in 
concussion studies. In this preliminary study, we compared arterial spin labeling measured 
cerebral blood flow (CBF) between concussed female club athletes 3-10 days post injury (mTBI) 
and demographic, HC/MC matched controls (CON). We test whether CBF mediates the 
relationship between progesterone levels in blood and post-injury symptoms, which may be 
evidence for progesterone’s role in neuroprotection. We found a significant three-way 
relationship between progesterone, CBF and perceived stress score (PSS) in the left middle 
temporal gyrus. Higher progesterone was associated with lower (more normative) PSS, as well 
as higher (more normative) CBF. CBF mediates 100% of the relationship between progesterone 
and PSS (Sobel’s p-value=0.017). These findings suggest progesterone may have a 
neuroprotective role after concussion and highlight the importance of controlling for the effects 
of sex hormones in future concussion studies.     
Introduction 
Concussion is a form of mild traumatic brain injury (mTBI) that accounts for the majority of 
the 300,000 sports-related brain injuries among high school and college athletes in the United 
States each year1. Prior concussions can lead to increased risk to subsequent concussions 2-4 and 
repetitive head impacts, whether resulting in a clinically diagnosable concussion or not, can lead 
to cumulative functional deficits5-7.  
Neuroimaging has consistently detected changes in the brain of concussed subjects both in 
the acute phase as well as during recovery 8-11. In fact, brain changes persist after post-
concussion symptoms have resolved 12, suggesting neuroimaging may offer increased sensitivity 
to study injury recovery. Cerebral blood flow (CBF) is emerging to be a useful metric for 
studying concussive injury and recovery, mainly due to its tight coupling to neuronal activity and 
involvement in inflammatory processes 13-17. In the acute phase of concussion, CBF is often 
reduced, and remains low during the recovery process 8, 12, 18, 19. It is also significantly correlated 
with symptom severity and cognitive performance 10, 20, providing a more objective and 
quantitative complement to clinical assessment. 
Collegiate athletes can be generally divided into varsity and club teams. According to the 
National Collegiate Athletic Association, the estimated number of varsity athletes in the US is 
460,000 21, whereas more than 2 million athletes participate in collegiate clubs 22. Despite the 
much larger number of club athletes, they tend to be less studied as they receive less resources 
and medical supervision, as well as less education about sports-related concussion 23, even 
though their practice schedule and probability of exposure to head trauma are comparable to 
varsity athletes.  
Another subgroup of athletes that are understudied are females. As of 2004-2005, 
approximately 41% of collegiate females participated in sports 24, which translates into roughly 
200,000 female athletes. However, most concussion studies to date have focused on male 
athletes. Those studies that have included females have either grouped them together with males 
or have not accounted for sex-specific factors such as hormonal fluctuations, which may lead to 
inconsistent findings. There is therefore a dire need for female athlete studies, especially since 
female athletes appear to have a higher prevalence for injuries and tend to have longer recovery 
time 25-27. A likely physiological factor accounting for these gender differences is hormones. 
Females experience significant fluctuations in the levels of estrogen and progesterone during the 
menstrual cycle (MC). These gonadal hormones have widespread non-reproductive functions in 
the central nervous system (CNS) 28 and have been shown to have neuroprotective effects in 
various disorders including ischemia, traumatic brain injury (TBI) and spinal cord injury in both 
animal models and humans 29-32.  
Further complicating the picture is the widespread use of hormonal contraceptives (HC), 
which use synthetic forms of estrogen and/or progesterone to inhibit the natural cycling of their 
levels to prevent pregnancy. It is estimated that 4 out of 5 sexually active women use hormonal 
oral contraceptives, and use of other hormonal contraceptive methods have been on the rise 33. 
HC users have been found to have lower post-concussive symptom severity compared to non-HC 
users34, 35. While HC use doesn’t affect length of recovery, it does appear to be associated with 
better cognitive performance after injury36.    
Hormonal fluctuations have also been reported to influence neuroimaging outcomes, which 
complicates data interpretation. For example, patterns of brain activations differed across the MC 
for emotional processing, verbal memory and visual-spatial tasks 37-43. Structural and 
connectivity differences across the MC have also been reported 44, 45. Similarly, neurometabolite 
concentrations have also been reported to fluctuate across the MC and may contribute to changes 
after exposure to HAEs 46. These findings highlight the importance of controlling for MC phase 
when studying concussion in female athletes, a methodology that has not yet been applied to this 
field of research. 
For the current study, we investigate whether levels of progesterone, a gonadal hormone that 
has demonstrated neuroprotective effects in brain injury, influences post-concussive symptom 
severity during the acute phase (i.e. 3-10 days post-injury) in female club athletes. We 
incorporated a rigorous MC tracking and HC user/non-HC user matching technique with arterial 
spin labeling (ASL), a noninvasive neuroimaging technique for measuring CBF, to understand 
whether CBF mediates this relationship, which can be considered evidence for progesterone 
having a neuroprotective role in concussion. We used a stepwise approach to reveal brain regions 
that have a three-way relationship between progesterone, symptom score and CBF. Mediation 
analysis was then applied to determine whether there is a directed pathway for the interactions.   
Methods 
Subjects 
At the beginning of each sports season, female athletes were approached and asked to fill 
out an online screener, which collects demographic information and self-report of MC start dates 
for the past 3 months. Injured athletes were identified by the university’s Athletics department 
and referred to the study team for enrollment into the study after obtaining written informed 
consent in compliance with guidelines of the university’s Internal Review Board. Study visits 
were divided into two consecutive days, where study assessments including: 1) Perceived Stress 
Scale (PSS) 47, Post-Concussive Symptom Scale (PCSS) 48, Beck Depression Inventory II (BDI-
II) 49 , caffeine consumption and alcohol and cannabis use for the past 30 days were collected on 
Day 1, and blood sampling and MRI were completed on Day 2. The study visits were scheduled 
within 3-10 days post-injury. Sixteen injured athletes were identified and recruited for this study, 
only 15 of them completed the MRI data collection. 
Sixteen control subjects were matched based on age, ethnicity, handedness and 
contraceptive use/type, recruited from non-collision sports teams. For MC matching purposes, all 
subjects were divided into 3 groups: (1) non-hormonal contraceptive users with regular MCs, (2) 
non-hormonal contraceptive users with irregular MCs and (3) hormonal contraceptive users. For 
non-hormonal contraceptive users, days 1-7 of MC were estimated as the follicular phase, and 
days 20 or higher were estimated as the luteal phase. Based on the 3 month timeline follow back 
MC tracking self-report, we scheduled the matched control subjects during the same MC phase 
the mTBI athlete was scanned in. For example, if the mTBI athlete was scanned during the 
follicular phase, the matched control was scheduled during days 1-7 of her MC. Users of 
hormonal contraceptives such as oral contraceptives or NuvaRing do not have normal MC as 
their hormones are suppressed, therefore their cycles were divided into active and inactive 
phases, depending on whether they were on the active hormone pills or with NuvaRing inserted, 
or placebo pills or NuvaRing not inserted. Control subjects were scheduled within 2 days of the 
matched mTBI athlete’s pill pack or NuvaRing day.  
MRI Acquisition 
Imaging data were acquired on a 3.0T whole body Siemens Prisma scanner (Erlangen, 
Germany), using a 64-channel head/neck receive-only coil. High resolution, T1-weighted 
anatomical images were collected using 3D-MPRAGE with the following parameters: 
TR/TE/TI/FA=2300ms/2.94ms/900ms/9°, 176 sagittal slices, 1mm isotropic resolution, iPAT 
acceleration factor=2, iPAT reference lines=38 (total duration=5min 37s). ASL data were 
collected using a 2D-EPI acquisition, using pseudo-continuous labeling 50. Other parameters 
include: TR/TE=4500ms/12ms, label duration=1.5s, post-labeling delay=1.8s, labeling plane 
offset=90mm from center of imaging slices, resolution 3.4x3.4x6mm3, 24 slices with 1.5mm gap 
acquired in ascending order, iPAT acceleration factor=2, 35 pairs of interleaved control and tag 
images (total duration=5min 29s).   
Cerebral Blood Flow mapping 
Imaging data were processed using in-house scripts written in Matlab R2016a (Mathworks, 
Natick, MA) with Statistical Parametric Mapping SPM8 (Wellcome Department of Imaging 
Neuroscience, London, UK). All ASL data were motion-corrected with the first image of the series 
as the reference and then co-registered to the high resolution anatomical image. Perfusion weighted 
images were generated by pairwise subtraction between control and tag images and averaged over 
the entire time-series.  Images were converted to quantitative CBF units in ml/100g/min using the 
single-blood-compartment model 51:  
𝑓𝑓 = 𝜆𝜆 ∙Δ𝑀𝑀 ∙ 𝑒𝑒𝑃𝑃𝑃𝑃𝑃𝑃/𝑇𝑇1𝑏𝑏2𝛼𝛼 ∙ 𝑀𝑀0 ∙ 𝑇𝑇1𝑏𝑏 ∙ (1− 𝑒𝑒− 𝜏𝜏𝑇𝑇1𝑏𝑏) 
Where f represents CBF in quantitative units, ∆M is the perfusion weighted signal, λ is the 
blood/water tissue partition coefficient (assumed to be 0.9 g/ml 52), α is the inversion efficiency 
assumed to be 0.85 50, M0 is the equilibrium magnetization from the control acquisition, and T1b is 
blood T1 assumed to be 1664ms 53. The quantitative CBF maps were then transformed to Montreal 
Neurological Institute (MNI) template space and up-sampled to 1.5mm isotropic resolution based 
on the transformation matrix calculated from the high-resolution anatomical image using VBM8 
54.  
Given the poor spatial resolution of the ASL acquisition, partial volume correction (PVC) 
is necessary to minimize contamination of ASL signal from different tissue types. Tissue 
probabilities from segmented gray and white matter maps of the high-resolution anatomical image 
were used to calculate true gray matter CBF based on the following equation, where the GM flow 
was assumed to be 2.5 times that of WM flow 55: 
𝑓𝑓𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 = 𝑓𝑓𝑢𝑢𝑢𝑢𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐(𝑃𝑃𝐺𝐺𝐺𝐺 + 0.4 ∗ 𝑃𝑃𝑊𝑊𝐺𝐺) 
To minimize artifacts due to low GM probability, only voxels with at least 30% GM were 
corrected. Voxels with less than 30% GM were set to 0. PVC maps were smoothed with 8mm 
FWHM kernel before entering into statistical analysis. 
Blood Draw 
For assessment of progesterone level, 1mL of blood was collected by a trained nurse of 
the Northwestern Memorial Hospital, outpatient Clinical Research Unit, and analyzed at the 
Northwestern Memorial Hospital Clinical lab. 
Data Analysis  
 Given the pilot sample size and multiple symptom scores, we sought to increase our 
statistical power by combine the PCSS, PSS and BDI scores into a composite score (CompositeZ). 
For each of these scores, a z-score was computed by subtracting the group mean of the controls 
from each subject’s score and dividing by the standard deviation of the controls. The composite 
score was calculated as the average of the 3 z-scores. Standard 2-sampled t-tests were used to 
determine group differences in the symptom and composite scores. 
 As the main focus of this study was to determine if there were any 3-way relationships 
between regional CBF, progesterone levels and symptom scores, we first computed Pearson’s 
correlation coefficients between symptom scores and progesterone levels to decide which 
symptom score to use for the imaging-based statistics.    
A stepwise process was used for the imaging-based analysis in Statistical Parametric 
Mapping (SPM8, Wellcome Institute). We first identified regions in the brain where the mTBI and 
CON groups differed in CBF. This was performed with a voxelwise two-sampled t-test, with each 
subject’s global GM CBF used to proportionally scale each subject’s CBF map to a global value 
of 50 mL/100g/min. Proportional scaling is necessary to eliminate variability arising from each 
subject’s global CBF level. Given the exploratory nature of this analysis on a small sample, we 
used a liberal threshold of p=0.05, cluster of 10 voxels.  
Within areas with significant group differences in CBF, we then used voxelwise multiple 
regression to identify regions where there was a significant correlation between symptom score 
and CBF. Each subject’s global CBF level and the number of days from injury to imaging were 
included as covariates. Contrasts for positive and negative correlations with symptom score were 
thresholded at p<0.005, cluster of at least 20 voxels. No correction for multiple comparison was 
used due to the exploratory, stepwise nature of this analysis. Regional CBF (rCBF) values were 
extracted from significant clusters, scaled by the scale factor calculated from proportional scaling, 
and used to compute Pearson’s correlation coefficients by correlating rCBF to progesterone levels.  
Clusters where rCBF significantly correlated with both symptom score and progesterone 
levels were entered into the mediation analysis, which included 1) a directed analysis, where 
progesterone was designated as the independent variable (IV) and cluster rCBF the mediator (M), 
and 2) a control analysis where cluster rCBF was designated as the IV and progesterone the M. In 
both analyses, the symptom score was the dependent variable. The following criteria need to be 
satisfied for a mediation relationship to be considered significant: 1) significant 3-way 
relationships between IV, M, and DV (i.e. paths A, B and C must all be statistically significant 
with p<0.05), 2) when mediator variable was added to regression between IV and DV, the standard 
beta coefficient was reduced and the regression was no longer significant, 3) direct mediation 
Sobel’s p-value < 0.05 and control mediation Sobel’s p-value > 0.05, and 4) % effect mediated for 
direction mediation should be greater than that for the control mediation. Mediations analyses were 
conducted in SPSS Version 26 and utilizing the mediation testing from MacKinnon and Dwyer 56. 
The first criteria mentioned above is essentially a conjunction analysis with a p-value threshold 
pa*pb*pc, where psubscript represents the p-value for that pathway. By requiring each of the pathways 
to have a p-value of 0.05 or less, the conjunction threshold p-value is therefore 
0.05*0.05*0.05=0.000125. For each mediation analysis, we compared the conjunction p-value to 
the Bonferroni corrected p-value of .00136 (.05/44), which is based on [ (3 areas where CBF was 
significantly related to progesterone, Path A) + (4 areas where CBF was significantly related to 
PSS_ZCon, Path B) + (4 symptom score relationships to progesterone levels tested, Path C)] x 2 
for mTBI and CON x 2 for directed mediation hypothesis testing where progesterone is the IV and 
CBF is the mediator and for control mediation testing where CBF is the IV and progesterone is the 
mediator. 
 
Results 
 A summary of the subject demographics, symptom scores and progesterone levels is 
shown in Table 1. Of the original sample of 15 mTBI and 15 control athletes that completed the 
MRI, one mTBI athlete did not have usable ASL data and was excluded with her matched 
control. Another pair of mTBI/control athletes was assessed during the luteal phase of their MC, 
where their progesterone levels were over 10 times higher than the rest of our cohort. Given the 
small sample size of this study, this pair of athletes also had to be excluded from the analysis, 
resulting in a final sample of 26 club female athletes (mTBI n=13, control n=13). Among the 
symptom scores including the composite score, all except the PCSS emotional subscore and BDI 
were significantly higher in the mTBI group. 
Table 1. Summary of demographics, symptoms and outcomes. 
 
 
M ± SD, Mean ± standard deviations; n.s., group comparisons are not significant at p<0.05 
level.   
 
 mTBI (n=13) CON (n=13) p-value 
Age (M ± SD) 20.2 ± 1.5 20.1 ± 1.1 n.s. 
N Hormonal contraceptive users 7 7 n.s. 
PCSS 21 ± 15 4 ± 4 0.003 
PCSS sleep 4 ± 4 1 ± 1 0.01 
PCSS emotional 2 ± 2 1 ± 2 n.s. 
PCSS cognitive 5 ± 4 0 ± 1 0.002 
PCSS physical 10 ± 7 2± 2 0.001 
PSS 15 ± 6 8 ± 5 0.002 
BDI 4 ± 6 1 ± 1 n.s. 
CompositeZ 2.09 ± 2.59  -0.22 ± 0.64 0.008 
Return to Play (days) 22 ± 14 - - 
Days to symptom baseline 1 ± 5 - - 
Days from injury to scan 7 ± 2 - - 
Progesterone (ng/mL) 0.48 ± 0.27 0.43 ± 0.32 n.s. 
 
 Table 2 shows the Pearson’s correlation coefficients (p-values) for groupwise correlations 
between individual symptom Z scores and the composite Z score with progesterone levels. Only 
PSS_ZCon was significantly correlated with progesterone levels in the mTBI group (r = -0.586, 
p = 0.035), such that as progesterone levels are higher, perceived stress symptoms are lower or 
less severe. Based on this finding, all subsequent imaging and mediation results are reported in 
reference to PSS_ZCon.  
Table 2. Pearson’s correlation coefficients (p-values) between symptom scores and 
progesterone levels.  
Symptom Score mTBI CON 
PCSS_ZCon -0.294 (0.329) -0.007 (0.983) 
PSS_ZCon -0.586 (0.035) -0.3 (0.319) 
BDI_ZCon -0.327 (0.275) 0.09 (0.769) 
Composite_ZCon -0.397 (0.179) -0.1 (0.745) 
 
Symptom scores were converted into Z scores based on the mean symptom scores of the CON 
group. Correlation between PSS_ZCon of mTBI group and progesterone level was the only 
one significant at p<0.05, highlighted in bold. 
 
 Figure 1 shows clusters with significant correlation between regional CBF and 
PSS_ZCon, overlaid onto a single subject’s high resolution anatomical image in MNI template 
space. All images are in neurological convention, where left side of the brain is on the left side of 
the image. Red clusters represent positive correlations, i.e. higher symptoms associated with 
higher rCBF, and blue clusters represent negative correlations. A summary of the clusters, 
including number of voxels for each cluster, MNI coordinates of the voxel with the highest T-
value, and anatomical labels based on the Harvard-Oxford cortical (48 regions) and subcortical 
(21 regions) atlases 57 and a probabilistic cerebellar atlas with 28 anatomical regions 58 are shown 
in Table 3. Four clusters had significant correlations between rCBF and progesterone for the 
mTBI group only: left superior parietal lobule (L. SPL), left medial temporal gyrus (L. MTG), 
superior left superior temporal gyrus (L. STG), and left precuneus. While the L. SPL cluster had 
a positive correlation between rCBF and PSS_ZCon (i.e. higher rCBF associated with higher or 
more severe PSS_ZCon), the remaining 3 clusters had negative correlations between rCBF and 
PSS_ZCon (lower rCBF associated with higher or more severe PSS_ZCon). No significant 
correlations to progesterone were found for the CON group in any of the clusters listed in Table 
3. Three of these clusters had significant correlations between rCBF and progesterone levels, 
again only in the mTBI group. The correlation coefficients and p-values between rCBF and 
progesterone levels for these clusters are shown in bold in Table 3.    
Figure 1. Clusters where CBF in mTBI group correlated with PSS_ZCon score, overlaid onto 
a single subject’s T1 in MNI space. Red represents positive correlation, i.e. higher PSS_ZCon 
score associated with higher CBF, and blue represents negative correlation, i.e. higher 
PSS_ZCon score associated with lower CBF. Clusters were generated by thresholding the 
results at p<0.005, at least 20 voxels for each contrast (positive and negative correlations with 
PSS_ZCon score), and only in regions where a significant group difference in CBF was 
detected. 
 
 
Table 3. Summary of clusters with significant correlation between CBF and the PSS_ZCon score in the mTBI group, masked by areas 
with significantly different CBF between mTBI and CON groups. Clusters were generated using a p-value threshold of 0.005 and 
cluster threshold of 20 voxels. The two rightmost columns show Pearson’s correlation coefficients and p-values in parentheses for 
correlations between CBF and progesterone levels for each group. Correlations with p-value < 0.05 are shown in bold. 
Abbreviations: Nvoxels, number of voxels in cluster; cereb., cerebellum; post., posterior; temporoocc, temporooccipital; ITG, 
Inferior Temporal Gyrus; MTG, Middle Temporal Gyrus; MFG, Middle Frontal Gyrus; SFG, Superior Frontal Gyrus; STG, Superior 
temporal gyrus; SPL, Superior Parietal Lobule; ant., anterior; sup., superior; SMA, Supplementary Motor Cortex. OUTSIDE means 
the cluster was not in a labeled region of the atlas.
+PSS, days to scan, proportional 
Nvoxels T equivZ p(unc) x,y,z (mm) anatomical label  mTBI vs. Prog CON vs. Prog 
21 5.534 3.663 0.0001 -36, -51, 46 Left SPL (59%), post. Left Supramarginal 
(26%) 
-0.562 (0.046) 0.028 (0.929) 
-PSS, days to scan, proportional 
Nvoxels T equivZ p(unc) x,y,z {mm} anatomical label  mTBI vs. Prog CON vs. Prog 
42 4.812 3.385 0.0004 -54, -48, 1 
Left MTG, temporoocc.(80%), OUTSIDE 
(18%), post. Left MTG (2%) 0.713 (0.006) 0.023 (0.94) 
27 4.179 3.107 0.0009 -58, -3, -11 Sup. Left STG (67%), ant. Left MTG (26%) 0.654 (0.015) 0.228 (0.455) 
32 3.767 2.905 0.0018 -8, -48, 42 
Left precuneus (59%), Right precuneus 
(27%), post. Left Cingulate (12%), post. 
Right Cingulate (2%) 0.506 (0.077) -0.286 (0.343) 
Figure 2.  Clusters where there were significant correlations between CBF and progesterone 
levels for the mTBI group. The corresponding CBF-PSS_ZCon and CBF-progesterone plots 
are shown to the right, where red represents mTBI group and black represents CON group. 
The boxplots in the rightmost column show the distribution of CBF values extracted from this 
cluster for the two groups. The red line represents the group mean CBF, and outliers are 
denoted by a red cross. 
 
 
The locations of the 3 clusters with significant three-way relationships between rCBF, 
PSS_ZCon and progesterone, and the corresponding two-way scatterplots are shown in Figure 2, 
with mTBI group in red and CON group in black. In the L. SPL cluster which had a positive 
correlation between rCBF and PSS_ZCon, the correlation between rCBF and progesterone was 
negative. Similarly, in the clusters with a negative correlation between rCBF and PSS_ZCon, the 
correlation between rCBF and progesterone was positive. None of the correlations was 
significant for the CON group. In all 3 clusters, mean CBF for the mTBI group was lower than 
that of the CON group (p<0.05). 
Mediation results are shown in Table 4, where odd-numbered rows represent the directed 
mediations, with progesterone as IV and rCBF as M, and even-numbered rows represent the 
control mediations, with rCBF as IV and progesterone as M. In all the directed mediation cases, 
paths A, B and C without M (model 1) were statistically significant, but after including the 
effects of M, path C (model 2) was no longer significant, suggesting rCBF is an effective 
mediator of the relationship between progesterone and PSS_ZCon. In all 3 clusters, the % effect 
of progesterone on PSS_ZCon mediated by rCBF were greater than the % effect of rCBF on 
PSS_ZCon mediated by progesterone, suggesting that only the directed mediation is valid. The 
L. MTG cluster, denoted by *, was the only cluster with a Sobel’s test p-value less than 0.05 and 
mediates 100% of the neuroprotective effect of progesterone on PSS_ZCon. Correcting for 
multiple comparisons, each conjunction analyses p-value of paths A, B, and C (pa*pb*pc) was 
less than the Bonferroni correction p = .05/44 = .00136 (rightmost column of Table 4). The 
location of this cluster, as well as scatterplots for paths A, B and C model 1 are shown in Figure 
3.  
Table 4. Mediation results for mTBI group, using CBF values extracted from the 3 ROIs where a significant correlation between CBF 
and progesterone were detected in Table 3. In all 3 ROIs, CBF mediates a higher percentage of the effect of the IV (progesterone) on 
DV (PSS_ZCON), compared to progesterone as a mediator for the relationship between CBF and PSS_ZCON. Sobel’s test p-value of 
< 0.1 was considered statistically significant and denoted with *. Correcting for multiple comparisons, each conjunction analyses p-
value (pa*pb*pc) was less than the Bonferroni correction p (Bonf) = .05/44 = .00136. 
 
 
  
  Path: 
Path A: IV predicting M Path B: M predicting DV 
Path C  
model 1: IV 
predicting DV no M 
Path C 
model 2: IV 
predicting DV with 
M 
% 
Effect 
Mediated 
Sobel 
Test 
p-value 
 
  
Model & 
Predictor(s): 
p(Bonf) 
= .00136 
IV M DV Std β p-value Std β p-value Std β p-value Std β p-value pa*pb*pc 
progesterone L. SPL PSS_ZCON -0.566 0.044 0.748 0.003 -0.585 0.036 -0.238 0.35 59 0.091 4.752E-6 
L. SPL progesterone PSS_ZCON -0.566 0.044 -0.585 0.036 0.748 0.003 0.613 0.03 18 0.368 4.752E-6 
progesterone L. MTG PSS_ZCON 0.728 0.005 -0.826 0.001 -0.585 0.036 0.034 0.898 100 0.017* 1.80E-7 
L. MTG progesterone PSS_ZCON 0.728 0.005 -0.585 0.036 -0.826 0.001 -0.851 0.008 0 0.896 1.80E-7 
progesterone L. STG PSS_ZCON 0.664 0.013 -0.772 0.002 -0.585 0.036 -0.13 0.636 78 0.052 9.36E-7 
L. STG progesterone PSS_ZCON 0.664 0.013 -0.585 0.036 -0.772 0.002 -0.685 0.028 11 0.630 9.36E-7 
Figure 3. Correlation plots of the 3-way relationship between progesterone, rCBF and PSS_ZCon of the L. MTG cluster, which had 
the strongest mediation effect. 
 
Discussion 
 In this pilot study, we investigated if progesterone, CBF and post-concussive symptoms 
are related in female collegiate club athletes assessed 3-10 days after sports-related concussion, 
compared to demographic, HC, and MC matched control athletes participating in non-contact 
sports. Our goal was to identify areas of the brain where CBF was significantly related to both 
progesterone levels and symptom outcomes in order to test this three-way relationship in a 
mechanistic mediation analysis, which may be construed as evidence for possible 
neuroprotective effects of progesterone in concussion. While various symptom scores including 
PCSS, a subset of its subscores, and PSS were all elevated in the mTBI group, only PSS was 
significantly correlated with progesterone levels in the mTBI group in a negative relationship, 
i.e. higher progesterone levels were associated with lower PSS scores. Using voxelwise 
statistical analysis, we found 3 brain regions, all localized in the left hemisphere, with a three-
way relationship between progesterone, CBF and PSS: left SPL, left MTG and left STG. 
Mediation analysis revealed only the left MTG cluster was statistically significant, based on 
Sobel’s test p-value of 0.017. rCBF mediated 100% of the relationship between progesterone and 
PSS in this cluster. 
 Progesterone is a gonadal hormone that is synthesized by the ovaries in females, and 
testes and the adrenal cortex in males 32. Progesterone mediates non-reproductive functions in the 
central nervous system via an array of progesterone receptors that are widely distributed in the 
brain 59. Various animal models of brain injury have demonstrated that progesterone has 
neuroprotective effects. In rats, progesterone administered before middle cerebral artery 
occlusion resulted in smaller areas of infarction and better outcome 60. It also improved 
functional measures when administered after stroke 61, 62. Progesterone also has neuroprotective 
effects in a rodent model of TBI, where levels of lipid peroxidation, cerebral edema and 
inflammatory proteins associated with brain damage were all reduced after progesterone 
administration 31, 63. Clinical trials in adult TBI patients have also reported positive outcomes 
associated with progesterone treatment including reduced death rate and improved functional 
outcomes 64-66. 
In our cohort, we found higher progesterone levels associated with lower PSS score, i.e. 
more normative levels. Concurrently, higher progesterone was also associated with higher rCBF 
values in the left MTG. Higher CBF has traditionally been associated with better tissue health 
and cognitive performance 67-69, so this finding suggests higher progesterone levels are 
associated with better tissue health. Our between group data demonstrating that CBF levels were 
lower for the mTBI relative to control athletes also suggest that higher CBF values are more 
normative. Further, we showed with mediation analysis that CBF mediates the relationship 
between progesterone and PSS, which can be viewed as evidence that progesterone has a 
neuroprotective role and that this in turn results in reduction of post-concussion symptom.    
The locus of this mediation relationship is a small cluster within the posterior part of the 
left MTG. The MTG is a known network hub that facilitates communication between parallel 
and distributed brain networks 70, 71. The posterior part of the MTG is an important center for 
semantic processing, which has been shown to be slightly left lateralized based on a meta-
analysis of 120 studies on semantic processing 72. This is a heteromodal region that is activated 
by both visual and auditory stimuli and is thought to integrate various types of stimuli and 
control semantic retrieval 72, 73. While it is not immediately obvious how the left MTG is 
associated with stress, there’s evidence this region is also involved in emotional face processing 
74 and implicated in social anxiety disorder, where functional connectivity of this network hub is 
impaired and proportional to both clinical and patient-reported symptom severity 75. 
The current finding warrants further investigation as the relationship between 
progesterone and CBF is not widely studied. Although CBF in females fluctuates over the course 
of the menstrual cycle during which the balance between estrogen and progesterone varies 
greatly, the exact mechanism is unclear 76. Different types of progestin in hormone replacement 
therapy for menopausal women also seem to play a role in modulating CBF 77. A natural 
extension of this study would be to include measures of estrogen in order to get the full picture, 
as estrogen and progesterone have been shown to work in an antagonized manner. Estrogen also 
has widely studied effects on CBF, primarily through the interaction between estrogen receptors 
and endothelial nitric oxide synthase 78.  
 The most obvious limitation of the current study is the small, pilot sample size, which 
limited our analysis to subjects within the follicular phase of the MC. A larger sample size will 
provide adequate statistical power to study both progesterone and estrogen across multiple 
phases of the MC to improve understanding of how the balance of these hormones might have 
neuroprotective effects. Furthermore, a larger sample size including more HC users may also 
help elucidate whether HC use is also related to CBF and post-injury outcomes. Another 
potential weakness is related to the nonspecific nature of the PSS score. PSS assesses a person’s 
ability to handle stress, which can vary even in healthy subjects without concussion. Armed with 
the current findings in the left MTG, which has a crucial role in semantic processing, future 
studies can use more specific tasks to determine if semantic processing is affected in concussed 
subjects. Finally, while our MC/HC use matching protocol helps to minimize measurement bias 
due to the effect of MC phases on neuroimaging measures, it does not allow us to determine 
whether hormone levels at time of injury also play a role in affecting symptoms and recovery. 
Inclusion of this information in future studies can help improve our understanding of the multi-
way relationship between hormones, neuroimaging measures and post-injury symptoms. 
In conclusion, we present results from a preliminary study examining how CBF factors 
into the neuroprotective effects of progesterone in a group of collegiate club female athletes after 
concussion. We found high progesterone levels associating with lower or more normative PSS 
scores, as well as higher rCBF in the left MTG, reflecting potential neuroprotective effects of 
progesterone. rCBF in the left MTG mediates 100% of progesterone’s relationship with PSS, 
which could be interpreted as the underlying mechanism. These findings warrant further 
investigation in a large-scale study to better understand the role of multiple hormones, both 
natural and synthetic, in influencing post-concussion symptoms by their actions in the brain. 
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